Novacyt Azione

Novacyt Numero di Graham

Il Numero di Graham di Novacyt (ALNOV.PA) al 15 ago 2026 è 2,98 GBP. L'anno precedente, Numero di Graham era 3,32 GBP — una variazione del -10,32% (inferiore).

Numero di Graham

2,98GBP

YoY

-10,32%

Ultimo aggiornamento:

Numero di Graham di Novacyt ammonta a 2026 2,98 GBP. Numero di Graham di Novacyt ammontava a 2025 3,32 GBP. Diminuisce del -10,32% inferiore rispetto all'anno precedente.
Access this data via the Eulerpool API

Novacyt Analisi delle Azioni

Cosa fa Novacyt? Novacyt SA is a leading biotechnology company specializing in the development and marketing of diagnostic products and technologies. The company was founded in 2006 and has experienced impressive growth since then. Its headquarters are located in Paris. Novacyt's business model revolves around the development and marketing of diagnostic products and technologies, particularly molecular diagnostic kits and reagents used for identification and quantification of microorganisms, viruses, and genetic differences. These products are commonly used in medical research, clinical diagnostics, and environmental analysis. Novacyt is divided into several divisions, each offering different products and services. Its diagnostic business specializes in the research, development, and marketing of molecular diagnostic kits, including the Primerdesign Kits specifically designed for COVID-19 identification. The company also provides laboratory and service offerings, such as DNA sequencing, qPCR analysis, sample preparation, and PCR disinfection. Additionally, Novacyt offers various diagnostic tests capable of detecting genetic differences and mutations. Its PathFlow division focuses on improving the process from diagnosis to therapy and follow-up, particularly for oncology patients. In response to the COVID-19 pandemic, Novacyt quickly launched a PCR test kit for COVID-19, which has been approved in numerous countries worldwide. Novacyt has successfully established itself as a key player in the fight against the pandemic. In summary, Novacyt SA is a leading biotechnology company specializing in the development and marketing of diagnostic products and technologies. Through its divisions, the company ensures the optimal utilization of molecular diagnostic tests. Novacyt has become an important player in the fight against the pandemic through its rapid response and development of molecular diagnostic kits for COVID-19, establishing itself as a reliable and innovative partner for medical research and clinical diagnostics. Novacyt è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su Novacyt azioni

Numero di Graham di Novacyt è 2,98 GBP nel 2026.

Su Eulerpool è possibile consultare lo sviluppo storico completo del Novacyt di Numero di Graham dal 2006, con valori annuali, grafici e analisi dettagliate.

Il Graham Number stima il prezzo massimo equo per un'azione sulla base dell'EPS e del valore contabile per azione, seguendo i principi di value investing di Benjamin Graham.

Access this data via the Eulerpool API

Qualità — Novacyt

Tutte le Metriche Finanziarie — Novacyt